Cecile Contin-bordes

Title: Cecile Contin-Bordes: Innovator in Thrombotic Microangiopathies Treatment

Introduction

Cecile Contin-Bordes is a notable inventor based in Mérignac, France. He has made significant contributions to the field of medicine, particularly in the treatment of thrombotic microangiopathies (TMA). His innovative work has led to the development of a unique pharmaceutical composition that utilizes clusterin for therapeutic purposes.

Latest Patents

Cecile Contin-Bordes holds 1 patent for his invention titled "Clusterin for use in the treatment of thrombotic microangiopathies." This patent outlines a pharmaceutical composition comprising clusterin, specifically designed for treating TMA. The invention also includes an ex vivo method for stratifying patients likely to benefit from clusterin treatment, based on the measurement of clusterin levels in biological samples.

Career Highlights

Throughout his career, Cecile has worked with esteemed institutions such as Université de Bordeaux and Centre Hospitalier Universitaire de Bordeaux. His research and innovations have garnered attention in the medical community, particularly for their potential impact on patient care in thrombotic conditions.

Collaborations

Cecile has collaborated with notable colleagues, including Yahsou Delmas and Patrick Blanco. Their combined expertise has contributed to advancing research in the field of thrombotic microangiopathies.

Conclusion

Cecile Contin-Bordes is a pioneering inventor whose work in the treatment of thrombotic microangiopathies showcases the importance of innovation in medicine. His contributions are poised to make a significant difference in patient outcomes.